Table 1 Demographic and clinical characteristics of participants at enrollment

From: Diagnostic accuracy of a liquid chromatography-tandem mass spectrometry assay in small hair samples for rifampin-resistant tuberculosis drug concentrations in a routine care setting

Characteristic MDR/XDR-TB cohort (primary)
Female sex — no./total no. (%) 56/57 (98%)
Median age (range) — yr 33 (22–58)
Time from most recent diagnosis to small hair sample collection (median, IQR) — days 144 (50–337)
Drug-resistance status — no./total no. (%)
 Pre-XDR/XDR-TB 36/57 (63%)
 MDR-TB 16/57 (28%)
 Poly-resistance 1/57 (2%)
 RR-TB 4/57 (7%)
Treatment Outcome — no./total no. (%)
 Loss to follow-up 14/57 (25%)
 Treatment failure 6/57 (11%)
 Relapse 3/57 (5%)
 Continuing Treatment 18/57 (32%)
 Cure 15/57 (26%)
 Complete 1/57 (2%)